New antiarrhythmic drugs: their place in therapy.
D000200:Action Potentials / Q000187:drug effects; D000404:Ajmaline / Q000627:therapeutic use; D000638:Amiodarone / Q000627:therapeutic use; D000813:Anilides / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D001073:Aprindine / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D044482:Benzeneacetamides; D001950:Bretylium Tosylate / Q000627:therapeutic use; D004206:Disopyramide / Q000627:therapeutic use; D016700:Encainide; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D016293:Moricizine; D009025:Morpholines / Q000627:therapeutic use; D010640:Phenothiazines / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D044482:Benzeneacetamides; D009025:Morpholines; D010640:Phenothiazines; D010880:Piperidines; D000404:Ajmaline; D016293:Moricizine; D001073:Aprindine; D001950:Bretylium Tosylate; D014700:Verapamil; D004206:Disopyramide; C015970:lorcainide; D000638:Amiodarone; D016700:Encainide